Skip to content

Calcitriol

Vitamin D3 Analog — ALIMENTARY TRACT AND METABOLISM

Also known as: 1,25-dihydroxyvitamin D3, Dihydroxyvitamin D3, rocaltrol, topitriol

OfpFDA approvedATC A11CC04ATC D05AX03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Calcitriol is an ofp drug in the Vitamin D3 Analog class catalogued in DrugCentral. It was first approved by the FDA in 1978. DrugCentral lists 10 molecular targets, including VDR, Vdr and VDR. Recorded indications include Hyperparathyroidism Secondary to Chronic Renal Failure, Hypocalcemia, Hypocalcemia from End-Stage Renal Disease with Dialysis and Hypoparathyroidism.

  • Approval status: ofp (first approved 1978 by the FDA).
  • Drug class: Vitamin D3 Analog.
  • Molecular targets: VDR, Vdr, VDR and VDR (10 listed in DrugCentral).
  • Indications: Hyperparathyroidism Secondary to Chronic Renal Failure, Hypocalcemia, Hypocalcemia from End-Stage Renal Disease with Dialysis, Hypoparathyroidism and Hypophosphatemia and others.
  • ATC code: A11CC04 (Vitamin D and analogues).
  • Molecular formula: C27H44O3; molecular weight 416.65 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (7)

  • Hyperparathyroidism Secondary to Chronic Renal Failure
  • Hypocalcemia
  • Hypocalcemia from End-Stage Renal Disease with Dialysis
  • Hypoparathyroidism
  • Hypophosphatemia
  • Plaque psoriasis
  • Renal osteodystrophy

Off-label uses (5)

  • Familial x-linked hypophosphatemic vitamin D refractory rickets
  • Neonatal hypocalcemic tetany
  • Rickets
  • Vitamin D deficiency
  • Vitamin D Dependent Rickets

Contraindications (8)

  • Arteriosclerosis obliterans
  • Hypercalcemia
  • Hypercalcemia associated with Sarcoidosis
  • Hyperphosphatemia
  • Hypervitaminosis D
  • Kidney disease
  • Kidney stone
  • Sarcoidosis

Mechanism & targets

Established pharmacologic classVitamin D3 Analog

Molecular targets (10)

TargetGeneActionActivity
Vitamin D3 receptorVDRunknownKi 10.60
Vitamin D3 receptorVdrunknownKi 10.30
Vitamin D3 receptorVDRunknownEC50 10.30
Vitamin D3 receptorVDRunknownKd 10.15
Vitamin D3 receptorVDRagonistEC50 8.40
Vitamin D3 receptor AvdraunknownEC50 8.26
Vitamin D-binding proteinGCunknownKd 7.62
Vitamin D3 receptorVdrunknownEC50 7.00
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialCYP27B1unknown—
Vitamin D 25-hydroxylaseCYP2R1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1978-08-17FDA—VALIDUS PHARMS

ATC classification

ATC codeTherapeutic hierarchy
A11CC04ALIMENTARY TRACT AND METABOLISM › VITAMINS › VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO › Vitamin D and analogues
D05AX03DERMATOLOGICALS › ANTIPSORIATICS › ANTIPSORIATICS FOR TOPICAL USE › Other antipsoriatics for topical use

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Recalled product1333.7
Hypercalcaemia836.0
Hypocalcaemia784.6
Appendicolith631.5
Appendicitis494.8
Blood phosphorus increased490.8
Milk-alkali syndrome464.4
Peritonitis bacterial394.7
Hyperphosphataemia371.6
Cardiogenic shock361.1
Drug hypersensitivity355.1
Calciphylaxis295.4

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Calcitriol is on its molecule page.

Molecular formulaC27H44O3
Molecular weight416.65 g/mol
CAS number32222-06-3
InChIKeyGMRQFYUYWCNGIN-NKMMMXOESA-N
PubChem CID5280453
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Calcitriol used for?

DrugCentral lists the following indications for Calcitriol: Hyperparathyroidism Secondary to Chronic Renal Failure, Hypocalcemia, Hypocalcemia from End-Stage Renal Disease with Dialysis, Hypoparathyroidism, Hypophosphatemia, Plaque psoriasis and Renal osteodystrophy.

How does Calcitriol work?

Its molecular targets in DrugCentral include VDR, Vdr, VDR and VDR.

When was Calcitriol first approved?

Calcitriol was first approved by the FDA in 1978.

What drug class does Calcitriol belong to?

Calcitriol is in the Vitamin D3 Analog class.

What is the chemical formula of Calcitriol?

Calcitriol has the molecular formula C27H44O3 and a molecular weight of 416.65 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1978-08-17
AgencyFDA
Targets10
Indications7
FormulaC27H44O3
DrugCentral ID466
Interactive profile